(Q39289664)

10 September 2017

Incorporation of a selective sigma-2 receptor ligand enhances uptake of liposomes by multiple cancer cells (English)

1 reference

10 September 2017

Yifei Zhang

1

1 reference

10 September 2017

Yixian Huang

2

1 reference

10 September 2017

Peng Zhang

3

1 reference

10 September 2017

Xiang Gao

4

1 reference

10 September 2017

Robert B Gibbs

5

1 reference

10 September 2017

Song Li

6

1 reference

10 September 2017

language of work or name

English

0 references

publication date

13 August 2012

1 reference

International Journal of Nanomedicine

10 September 2017

1 reference

10 September 2017

7

1 reference

10 September 2017

4473-4485

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

10 September 2017

start time

1 August 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Use of multifunctional sigma-2 receptor ligand conjugates to trigger cancer-selective cell death signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

The pharmacology of sigma-1 receptors

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Pharmacology and therapeutic potential of sigma(1) receptor ligands

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Sigma-2 receptors as a biomarker of proliferation in solid tumours

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

SV119-gold nanocage conjugates: a new platform for targeting cancer cells via sigma-2 receptors

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Targeted intracellular delivery of antisense oligonucleotides via conjugation with small-molecule ligands.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Successful in vivo tumor targeting of prostate-specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugate

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Synthesis of N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl carbamate analogs as sigma2 receptor ligands

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Haloperidol-associated stealth liposomes: a potent carrier for delivering genes to human breast cancer cells

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Efficient intracellular delivery of oligonucleotides formulated in folate receptor-targeted lipid vesicles

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422102

Sigma 2 receptors as potential biomarkers of proliferation in breast cancer

21 August 2018

1 reference

12 December 2020

A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoethyl)4-iodobenzamide

1 reference

12 December 2020

Biofunctionalized targeted nanoparticles for therapeutic applications

1 reference

12 December 2020

Drug delivery systems: application of liposomal anti-tumor agents to neuroectodermal cancer treatment

1 reference

12 December 2020

Correlation between sigma2 receptor protein expression and histopathologic grade in human bladder cancer

1 reference

12 December 2020

Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro

1 reference

12 December 2020

Identifiers

DOI

10.2147/IJN.S31981

1 reference

10 September 2017

1 reference

10 September 2017

PubMed publication ID

22927761

1 reference